Skip to content
MARKETS / NYSE / EVH
NYSE · SERVICES-MANAGEMENT SERVICES · LARGE CAP

Evolent Health, Inc. EVH

13 fiscal years on record · USD · FY2025 reported · SEC filings only
$1.9B
▼ 26.6% YoY
$-534.5M
In brief

What this company does

Evolent Health, Inc. derives the majority of its revenue from its Specialty Care Management Services solution and also offers administrative services to its customers. As of February 16, 2026, the company had approximately 4,200 global employees. Its Specialty Care Management Services solution assembles networks of providers, designs evidence-based clinical pathways, and deploys specialty care management technology. Its Administrative Services solution provides regional and national payers and providers with financial and administrative management services, including health plan services, risk management, analytics and reporting, and leadership and management. Evolent was founded in 2011 by members of its management team, UPMC, an integrated delivery system in Pittsburgh, Pennsylvania, and The Advisory Board Company. Evolent Health, Inc. was incorporated in the State of Delaware in December 2014.

Written from the business description in Evolent Health, Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 25 February 2026. Every sentence was checked against that document before publication.

Growth
USD 1.9B
Revenue, FY2025 · full 13-year series below
Revenue $B Net income $B
FY2025 · Revenue 1.9 · Net income -0.5
1.0B2.0B-0.2B-0.4B2013201520172019202120232025
Compound annual growth
+11.5%
+15.2%
+34.5%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +15.2% a year over five years.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability
−31 cents
lost on every revenue dollar
Operating margin Net margin
FY2025 · Operating -21.9% · Net -30.9%
100%200%300%-50%2013201520172019202120232025
ROE
FY2025 · ROE -75.5%
50%100%-20%-40%-60%2013201520172019202120232025

Each USD of equity lost 75 cents this year.

Cash & shareholders
USD 40.0M
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2019 · FCF -78.2
-40M2013201520172019202120232025
Net buybacks $M Dividends $M
FY2025 · Dividends — · Net buybacks 40.0
20M-5M-10M202320242025

USD 40.0M in buybacks went back to shareholders in a year without profit.

Total assetsUSD 1.9B
EquityUSD 415.2M
CashUSD 151.9M
Gross debtUSD 970.5M
Net debtUSD 818.7M
Current ratio1.31×

Net debt stands at 197% of equity.

The 13-year record
13 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative
Metric 2025202420232022202120202019201820172016201520142013
Revenue $B1.92.62.01.40.90.90.70.60.40.30.10.00.0
Operating income $B−0.4−0.0−0.10.0−0.0−0.3−0.3−0.0−0.1−0.2−0.00.0−0.0
EBITDA $B−0.30.10.10.10.0−0.2−0.2−0.0−0.0−0.2−0.00.0−0.0
Income tax $B−0.0−0.0−0.1−0.00.0−0.0−0.00.0−0.0−0.00.00.00.0
Net income $B−0.5−0.1−0.1−0.0−0.0−0.3−0.3−0.1−0.1−0.20.3−0.00.0
Free cash flow $B······−0.1−0.1−0.1−0.1−0.00.0−0.0
EPS, diluted $−5.07−0.81−1.28−0.20−0.44−3.94−3.67−0.68−0.94−3.556.93−13.460.99
Dividend / sh $·············
Payout %·············
ROE %−75.5−6.0−11.7−2.5−5.7−43.2−29.1−4.9−7.1−23.6102.7··

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance
Company facts, as filed
How we verify · 0 failures in 50 reconciliationsAUDITED

Reconciled in 13 of 19 fiscal years. 39 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityServices-Management Services
Listed onNYSE
Incorporated inDelaware
Fiscal year endsDecember 31
Data on record since2013

Share this section

Download image